Skip to content

Monark Criticare: India’s critical care Colistimethate Sodium Injection IP 2 Million IU

GMP conditionsBatch released
Colizor-2-MIU Injection, Colistimethate Sodium Injection IP 2 Million IU, manufactured by Monark CriticareClick to enlarge
Anti-Infective

Colizor-2-MIU Injection

Colistimethate Sodium Injection IP 2 Million IU

Packing2MIU VIAL
PresentationInjection
  • Released against specification
  • Certificate of analysis enclosed
  • Injection presentation
  • Pan-India dispatch
Product priceMRP, inclusive of all taxes
₹1,990
  • 300 injectables
  • 19 therapeutic groups
  • One distributor per district

Uses of Colizor-2-MIU Injection

Managing infections caused by resistant bacteria requires a carefully selected antibiotic approach. Colizor-2-MIU Injection contains Colistimethate Sodium IP 2 Million IU, a prescription antibacterial medicine used for specific serious infections caused by susceptible Gram-negative bacteria. It may be prescribed by specialists when the available treatment choices are limited or when laboratory findings support its use.

With its activity against certain difficult-to-treat bacterial organisms, Colistimethate Sodium Injection IP 2 Million IU has an important role in selected hospital-based treatment plans. Its suitability depends on infection type, bacterial susceptibility, and individual patient assessment.

Therapeutic applications at a glance:

  • Resistant bacterial infections: Selected infections caused by susceptible multidrug-resistant organisms.
  • Severe Gram-negative infections: Specialist-managed infections requiring targeted antibiotic therapy.
  • Hospital treatment protocols: Use in appropriate inpatient clinical settings.
  • Culture-guided treatment: Antibiotic selection supported by laboratory susceptibility reports.
  • Specialist-directed therapy: Selected cases where alternative antibiotics are unsuitable.

Indication categories, not an exhaustive list, and not a recommendation for any individual patient.

Quality-driven manufacturing behind Colizor-2-MIU Injection

124
Injectables in the live range
19
Therapeutic groups covered
4
Dosage forms manufactured
1
Distributor per district
Territory

PCD pharma franchise for Colizor-2-MIU Injection, available across India

Enquiries accepted from every state and union territory. Whether a specific district is still open changes week to week, so it is answered by a person rather than by this page.

North8
  • Punjab
  • Haryana
  • Himachal Pradesh
  • Jammu & Kashmir
  • Uttarakhand
  • Delhi NCR
  • Rajasthan
  • Uttar Pradesh
West & Central5
  • Gujarat
  • Maharashtra
  • Goa
  • Madhya Pradesh
  • Chhattisgarh
South6
  • Karnataka
  • Kerala
  • Tamil Nadu
  • Andhra Pradesh
  • Telangana
  • Puducherry
East & North-East12
  • Bihar
  • Jharkhand
  • Odisha
  • West Bengal
  • Assam
  • Meghalaya
  • Tripura
  • Manipur
  • Nagaland
  • Mizoram
  • Arunachal Pradesh
  • Sikkim

Exclusive district rights — one distributor per district, named in the agreement.

Check my district
The comparison

Why Monark Criticare versus a typical supplier?

Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.

Factor
Monark Criticare
Typical supplier
Territory
One distributor per district, named in the agreement
Shared, rarely written down
Rate list
Net rates, pack sizes and MRP issued up front
On request, after commitment
First orders
No minimum on the first two order cycles
High minimum from the start
Batch paperwork
Certificate of analysis travels in the consignment
Emailed later, if chased
Manufacturing
GMP conditions, every batch released against specification
Varies by site
Range depth
124 injectables across 19 therapeutic groups
Thin outside the fast movers
Dispatch
Pan-India from one site, cold chain where the molecule needs it
Multi-site, variable
Reply time
Usually inside one working day
Days, or not at all
Territory
Monark CriticareOne distributor per district, named in the agreement
Typical supplierShared, rarely written down
Rate list
Monark CriticareNet rates, pack sizes and MRP issued up front
Typical supplierOn request, after commitment
First orders
Monark CriticareNo minimum on the first two order cycles
Typical supplierHigh minimum from the start
Batch paperwork
Monark CriticareCertificate of analysis travels in the consignment
Typical supplierEmailed later, if chased
Manufacturing
Monark CriticareGMP conditions, every batch released against specification
Typical supplierVaries by site
Range depth
Monark Criticare124 injectables across 19 therapeutic groups
Typical supplierThin outside the fast movers
Dispatch
Monark CriticarePan-India from one site, cold chain where the molecule needs it
Typical supplierMulti-site, variable
Reply time
Monark CriticareUsually inside one working day
Typical supplierDays, or not at all

Start your critical care business with Colizor-2-MIU Injection — take the district before it is allocated

Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.

Get franchise quote

Get franchise quote for Colizor-2-MIU Injection

Interested in Colistimethate Sodium Injection IP 2 Million IU for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.

  • ✓Exclusive district rights, recorded in the agreement
  • ✓Net rates, pack sizes and MRP issued before you commit
  • ✓No minimum on the first two order cycles
  • ✓Batch documentation and certificate of analysis with every consignment

Send enquiry

Fill in your details and we will contact you shortly.

Colizor-2-MIU Injection  |  Colistimethate Sodium Injection IP 2 Million IU

This website is a business to business platform intended for pharmaceutical traders, distributors, wholesalers, hospitals and healthcare professionals. Product compositions, therapeutic categories and portfolio information are published for commercial and educational reference only.

Nothing here is medical advice, a prescribing recommendation or a substitute for professional diagnosis or treatment. We do not sell medicines directly to individuals, and all trade enquiries are subject to verification of a valid drug licence before any supply is agreed.

The details you send are used to answer this enquiry and to contact you about it, by phone, WhatsApp or email. They are not sold and not passed to anyone outside this company.

Read the full privacy policy

Tick the box above to enable this button

Or call us: +91 90567 60548 | +91 98886 56719

Related products

View all products →